Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
- Status
- TERMINATED
- Phase
- PHASE2
FTS Study in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
- Status
- COMPLETED
- Phase
- PHASE3
RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Collection and Banking of Leukemia Cells MDS/AML
- Status
- COMPLETED
- Phase
- NA
Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2